Affluent Partners Holdings (1466) AI Stock Analysis

• Market Cap: HK$563.85M
• Dividend Yield: N/A
• Average Volume (3M): 294.14K
• Price to Earnings (P/E): ―
• Beta (1Y): 0.30
• Revenue Growth: 60.41%
• EPS Growth: -185.00%
• Country: HK
• Employees: 84
• Sector: Consumer Cyclical
• Sector Strength: 59
• Industry: Luxury Goods
• EPS (TTM): -0.02
• Shares Outstanding: 772,391,050
• 10 Day Avg. Volume: 195,000
• 30 Day Avg. Volume: 294,137
• PEG Ratio: N/A
• Price to Book (P/B): N/A
• Price to Sales (P/S): 0.00
• Price to Cash Flow (P/CF): 0.00
• P/FCF Ratio: 0.00
• Enterprise Value/Market Cap: N/A
• Enterprise Value/Revenue: N/A
• Enterprise Value/Gross Profit: N/A
• Enterprise Value/Ebitda: N/A
• 1Y Price Target: N/A
• Price Target Upside: N/A
• Rating Consensus: N/A
• Number of Analyst Covering: 0

Affluent Partners Holdings is currently facing significant financial difficulties with declining revenues and negative cash flows. While the technical analysis shows positive price trends, the company's poor valuation metrics highlight a lack of profitability. The main strengths are its moderate leverage and adequate liquidity, which provide some stability. However, the major risks are the ongoing financial losses and lack of earnings visibility, resulting in a low overall score.

Affluent Partners Holdings Business Overview & Revenue Model

Company Description

Affluent Partners Holdings Limited (1466) is a Hong Kong-based investment holding company primarily engaged in the distribution and trading of gemstones and jewelry. The company operates through its subsidiaries, which specialize in the design, sourcing, and distribution of a variety of fine jewelry and precious gemstones. Affluent Partners Holdings aims to leverage its expertise in the luxury goods market by expanding its product offerings and enhancing its distribution network.

How the Company Makes Money

Affluent Partners Holdings generates revenue mainly through the sale of gemstones and jewelry. The company sources raw gemstones, which are then processed and crafted into fine jewelry pieces, or sold as loose stones to other jewelry manufacturers and retailers. The primary revenue streams include wholesale distribution to retailers and direct sales to consumers through various channels. Strategic partnerships with suppliers and retailers enhance its market reach and distribution capabilities. Additionally, the company may engage in joint ventures or collaborations to expand its product lines and access new markets, contributing to its overall earnings.

Affluent Partners Holdings Financial Statement Overview

Summary

Income Statement

Balance Sheet

Cash Flow

Breakdown
Mar 2024	Mar 2023	Mar 2022	Mar 2021	Mar 2020
Income Statement		Total Revenue
53.68M	86.88M	62.65M	43.32M	111.98M
	Gross Profit
18.10M	7.83M	10.99M	-8.62M	28.55M
	EBIT
-9.58M	9.54M	-11.09M	-47.64M	-272.22M
	EBITDA
-6.32M	11.13M	-9.73M	-45.45M	-239.50M
	Net Income Common Stockholders
-7.45M	8.73M	-15.46M	-51.78M	-281.82M
Balance Sheet		Cash, Cash Equivalents and Short-Term Investments
37.88M	41.26M	23.59M	24.42M	34.49M
	Total Assets
196.80M	99.85M	82.11M	91.77M	158.66M
	Total Debt
51.19M	2.76M	31.84M	31.56M	39.50M
	Net Debt
13.31M	-38.50M	8.25M	7.13M	5.01M
	Total Liabilities
84.01M	21.51M	46.24M	45.82M	73.53M
	Stockholders Equity
96.31M	78.34M	35.87M	45.95M	85.13M
Cash Flow		Free Cash Flow
-6.64M	-21.55M	1.06M	-16.21M	-1.29M
	Operating Cash Flow
-6.46M	-21.52M	1.11M	-16.18M	2.33M
	Investing Cash Flow
4.74M	35.30M	-60.00K	138.00K	39.15M
	Financing Cash Flow
819.00K	3.70M	-1.72M	6.77M	-35.22M

Affluent Partners Holdings Technical Analysis

• Technical Analysis Sentiment: Positive
• Last Price: 0.73
• 50DMA: Positive
• 100DMA: Positive
• 200DMA: Positive
• MACD: Positive
• RSI: Neutral
• STOCH: Neutral

Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For HK:1466, the sentiment is Positive. The current price of 0.73 is above the 20-day moving average (MA) of 0.68, above the 50-day MA of 0.60, and above the 200-day MA of 0.56, indicating a bullish trend. The MACD of 0.02 indicates Positive momentum. The RSI at 64.10 is Neutral, neither overbought nor oversold. The STOCH value of 75.66 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Positive sentiment for HK:1466.

Affluent Partners Holdings Peers Comparison

Name	Overall Rating	Market Cap	P/E Ratio	ROE	Dividend Yield	Revenue Growth	EPS Growth
1234	68 Neutral	€4.49B	8.98	11.39%	10.44%	1.38%	-14.80%
Sector *	61 Neutral	$6.65B	11.71	3.09%	3.98%	2.65%	-20.82%
0866	52 Neutral	HK$2.74B	5.00	87.02%	―	-26.23%	147.88%
1466	51 Neutral	HK$563.85M	―	-14.00%	―	60.41%	-185.00%
0333	46 Neutral	HK$65.93M	―	-1.92%	―	20.02%	90.55%
2226	28 Underperform	HK$381.98M	―		―	4.26%	3.24%

Affluent Partners Holdings Corporate Events

Baijin Life Science Completes New Share Issuance

Baijin Life Science Holdings Limited has completed the issuance of new shares under a general mandate, resulting in a change in the company’s shareholding structure. The completion of this subscription process on March 28, 2025, has generated net proceeds of approximately HK$31,273,000, which are expected to be used for the general working capital of the group. This move is likely to impact the company’s operational liquidity and market positioning, as it adjusts its shareholding distribution among various stakeholders.

Baijin Life Science Holdings Announces Auditor Change to Baker Tilly

Baijin Life Science Holdings Limited has announced a change in its auditing firm. Moore CPA Limited has resigned due to a disagreement over audit fees, and Baker Tilly Hong Kong Limited has been appointed as the new auditor. The company assures stakeholders that the change will not impact the audit process or the release of financial results for the period ending March 31, 2025. The Board and Audit Committee believe that Baker Tilly’s appointment will enhance cost-effectiveness and maintain audit quality, benefiting the company and its shareholders.

Baijin Life Science Clarifies Share Subscription Details

Baijin Life Science Holdings Limited has issued a supplemental announcement regarding the subscription of new shares under a general mandate. The company clarified clerical errors related to the subscription price and provided updates on the shareholding structure, indicating changes in share distribution among subscribers and other stakeholders. The announcement also noted that proceeds from a previous subscription have been fully utilized.

Baijin Life Science Announces New Share Subscription Agreement

Baijin Life Science Holdings Limited has announced a new share subscription agreement, issuing 65,359,433 new shares at HK$0.48 each, representing approximately 9.24% of its existing share capital. This move, under the General Mandate, aims to enhance the company’s capital base, with the shares to be listed on the Stock Exchange, though completion is contingent on certain conditions being met.